289 related articles for article (PubMed ID: 30084972)
21. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
[TBL] [Abstract][Full Text] [Related]
23. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
[TBL] [Abstract][Full Text] [Related]
24. CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder.
Jiang T; Wang Y; Wang X; Xu J
Front Neurosci; 2022; 16():988265. PubMed ID: 36061599
[TBL] [Abstract][Full Text] [Related]
25. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.
Genin EC; Plutino M; Bannwarth S; Villa E; Cisneros-Barroso E; Roy M; Ortega-Vila B; Fragaki K; Lespinasse F; Pinero-Martos E; Augé G; Moore D; Burté F; Lacas-Gervais S; Kageyama Y; Itoh K; Yu-Wai-Man P; Sesaki H; Ricci JE; Vives-Bauza C; Paquis-Flucklinger V
EMBO Mol Med; 2016 Jan; 8(1):58-72. PubMed ID: 26666268
[TBL] [Abstract][Full Text] [Related]
26. Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
Nguyen MK; McAvoy K; Liao SC; Doric Z; Lo I; Li H; Manfredi G; Nakamura K
Hum Mol Genet; 2022 May; 31(9):1500-1518. PubMed ID: 34791217
[TBL] [Abstract][Full Text] [Related]
27. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.
Perrone F; Nguyen HP; Van Mossevelde S; Moisse M; Sieben A; Santens P; De Bleecker J; Vandenbulcke M; Engelborghs S; Baets J; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Martin JJ; Van Damme P; Van Broeckhoven C; van der Zee J;
Neurobiol Aging; 2017 Mar; 51():177.e9-177.e16. PubMed ID: 28069311
[TBL] [Abstract][Full Text] [Related]
28. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
[TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.
Teyssou E; Chartier L; Albert M; Bouscary A; Antoine JC; Camdessanché JP; Rotolo F; Couratier P; Salachas F; Seilhean D; Millecamps S
Neurobiol Aging; 2016 Jun; 42():218.e1-3. PubMed ID: 27095681
[TBL] [Abstract][Full Text] [Related]
30. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.
Purandare N; Somayajulu M; Hüttemann M; Grossman LI; Aras S
J Biol Chem; 2018 Apr; 293(17):6517-6529. PubMed ID: 29540477
[TBL] [Abstract][Full Text] [Related]
31. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
[TBL] [Abstract][Full Text] [Related]
32. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
[TBL] [Abstract][Full Text] [Related]
33. Structures of the Wild-Type and S59L Mutant CHCHD10 Proteins Important in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
ACS Chem Neurosci; 2022 Apr; 13(8):1273-1280. PubMed ID: 35349255
[TBL] [Abstract][Full Text] [Related]
34. Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Ren YL; Jiang Z; Wang JY; He Q; Li SX; Gu XJ; Qi YR; Zhang M; Yang WJ; Cao B; Li JY; Wang Y; Chen YP
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38453793
[TBL] [Abstract][Full Text] [Related]
35. ALS/FTD mutations in UBQLN2 are linked to mitochondrial dysfunction through loss-of-function in mitochondrial protein import.
Lin BC; Phung TH; Higgins NR; Greenslade JE; Prado MA; Finley D; Karbowski M; Polster BM; Monteiro MJ
Hum Mol Genet; 2021 Jun; 30(13):1230-1246. PubMed ID: 33891006
[TBL] [Abstract][Full Text] [Related]
36. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients.
Chiò A; Mora G; Sabatelli M; Caponnetto C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Battistini S; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; ; Brunetti M; Barberis M; Restagno G; Penco S; Lunetta C
Neurobiol Aging; 2015 Apr; 36(4):1767.e3-1767.e6. PubMed ID: 25726362
[TBL] [Abstract][Full Text] [Related]
37. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
[TBL] [Abstract][Full Text] [Related]
38. Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.
Liu T; Wetzel L; Zhu Z; Kumaraguru P; Gorthi V; Yan Y; Bukhari MZ; Ermekbaeva A; Jeon H; Kee TR; Woo JA; Kang DE
Cells; 2023 Dec; 12(24):. PubMed ID: 38132101
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
Zhou ZD; Saw WT; Tan EK
Mol Neurobiol; 2017 Sep; 54(7):5534-5546. PubMed ID: 27631878
[TBL] [Abstract][Full Text] [Related]
40. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF
Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]